Published in Gastroenterology on August 04, 2015
miR-517a is an independent prognostic marker and contributes to cell migration and invasion in human colorectal cancer. Oncol Lett (2016) 0.81
Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. Am J Prev Med (2016) 0.76
Octogenarian patients with colorectal cancer: Characterizing an emerging clinical entity. World J Gastroenterol (2017) 0.75
Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Colorectal cancer screening is cost-effective in the elderly who have had less intense prior screening, high baseline risk of colorectal cancer and less comorbidities. Evid Based Med (2016) 0.75
Modeling Individual Patient Preferences for Colorectal Cancer Screening Based on Their Tolerance for Complications Risk. Med Decis Making (2016) 0.75
Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study. BMC Cancer (2017) 0.75
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet (1996) 20.53
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 16.82
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet (2010) 15.50
American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol (2009) 12.16
Cancer screening in elderly patients: a framework for individualized decision making. JAMA (2001) 9.79
Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2012) 8.51
Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst (1999) 8.08
Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst (2008) 7.85
Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol (2006) 6.03
Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med (2012) 4.47
Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst (2003) 3.71
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold. N Engl J Med (2014) 3.57
Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med (2009) 3.34
Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut (1982) 3.23
Overuse of screening colonoscopy in the Medicare population. Arch Intern Med (2011) 3.08
The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer (1982) 2.85
Adenomatous polypi of large intestine: incidence and distribution. Ann Surg (1963) 2.74
Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol (2008) 2.56
INCIDENCE AND DISTRIBUTION OF ADENOMATOUS POLYPS OF THE COLON AND RECTUM BASED ON 1,000 AUTOPSY EXAMINATIONS. Dis Colon Rectum (1964) 2.54
Adenomatous lesions of the large bowel: an autopsy survey. Cancer (1979) 2.41
Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 2.31
Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med (2014) 2.31
Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med (2009) 2.24
Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut (1992) 2.15
Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer (1985) 2.08
Older adults and forgoing cancer screening: "I think it would be strange". JAMA Intern Med (2013) 2.08
Individualizing colonoscopy screening by sex and race. Gastrointest Endosc (2009) 1.96
Polyps of the large intestine in Aarhus, Denmark. An autopsy study. Scand J Gastroenterol (1989) 1.79
Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies. Ann Intern Med (2013) 1.62
Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol (2008) 1.59
Polyps of the colon in Barcelona, Spain. An autopsy study. Cancer (1988) 1.57
Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine. Pharmacoeconomics (1997) 1.56
Univariate solutions in a multivariate world: can we afford to practice as in the "good old days"? Am J Manag Care (2005) 1.55
A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials. Cancer (2009) 1.37
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med (2014) 1.32
Utility valuations for outcome states of colorectal cancer. Am J Gastroenterol (1999) 1.30
The incidence and cost of unexpected hospital use after scheduled outpatient endoscopy. Arch Intern Med (2010) 1.25
Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study. BMJ (2014) 1.24
Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region. JAMA Intern Med (2013) 1.22
Secular trends in colon and rectal cancer relative survival. J Natl Cancer Inst (2013) 1.16
The appropriateness of more intensive colonoscopy screening than recommended in Medicare beneficiaries: a modeling study. JAMA Intern Med (2014) 1.00
Provider recommendations for colorectal cancer screening in elderly veterans. J Gen Intern Med (2009) 1.00
Colonoscopy utilization and outcomes 2000 to 2011. Gastrointest Endosc (2014) 0.96
How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer? Cancer (2011) 0.93
Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer (2015) 1.25
The appropriateness of more intensive colonoscopy screening than recommended in Medicare beneficiaries: a modeling study. JAMA Intern Med (2014) 1.00
Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. JAMA (2016) 0.96
Smarter screening for cancer: possibilities and challenges of personalization. JAMA (2014) 0.91
Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clin Gastroenterol Hepatol (2016) 0.83
Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacity. Cancer (2016) 0.79
Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History. J Natl Cancer Inst (2020) 0.75
Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. JAMA (2017) 0.75